Abstract
ABSTRACT
In recent years, multiple novel and improved therapies have become available to treat alopecia disorders. Whereas many therapeutics are entirely new, some medications, such as oral minoxidil, have been available for years and are just now being revisited as potentially valuable hair loss treatments. This article discusses the risks, benefits, and potential side effects of the off-label use of low-dose oral minoxidil. It compares low-dose oral minoxidil with topical minoxidil, a well-established and FDA-approved treatment for androgenetic alopecia, but one that is often associated with poor overall adherence. Finally, nursing considerations in the education and care of patients with alopecia disorders and associated medications are discussed.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference16 articles.
1. Platelet-rich plasma in the treatment of alopecia areata: A review;Journal of Investigative Dermatology Symposium Proceedings,2020
2. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial;Journal of Cosmetic Dermatology,2023
3. Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series;Journal of the American Academy of Dermatology,2021
4. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review;International Journal of Women's Dermatology,2018
5. The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial;Stem Cells Translational Medicine,2015